Terns Pharmaceuticals, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 52.95 USD (At close: May 4, 2026) · Market cap 6.11B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in Phase 1/2 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced metabolic stability and liver distribution that is in Phase IIa clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis (MASH); and TERN-801 series of small-molecule glucose-dependent insulinotropic polypeptide receptor (GIPR) modulators for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.
Details
| Name | Terns Pharmaceuticals, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 59 |
| Founded | 2017 |
| Ipo Date | 2021-02-05 |
| Ceo | Amy Burroughs |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 17.00 |
| Isin | US8808811074 |
| Cusip | 880881107 |
| Cik | 1831363 |
| Sic | 2834 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Amy L. Burroughs M.B.A. | Chief Executive Officer and Director |
| Melita Sun Jung | Chief Business Officer |
| Andrew W. Gengos | Chief Financial Officer and Head of Corporate Development |
| Scott Harris | Chief Development and Operations Officer |
| Caryn Gordon McDowell J.D. | Chief Legal Officer |
| Theresa Clouser | Vice President of Marketing |
| Robin Andrulevich | Chief People Officer |
| Dr. Jeffrey R. Jasper Ph.D. | SVice President and Senior Distinguished Research Fellow |
| Dr. Emil T. Kuriakose M.D. | Chief Medical Officer |
| Debra Sieminski | Senior Vice President of Medical Affairs |
Contact
| Address | 1065 East Hillsdale Boulevard, Suite 100, Foster City, California 94404, United States |
| Phone | 650 525 5535 |
| Website | https://www.ternspharma.com |